WAY 151616

Drug Profile

WAY 151616

Alternative Names: KCO 616

Latest Information Update: 25 Oct 2005

Price : $50

At a glance

  • Originator Wyeth
  • Class
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Urinary incontinence

Most Recent Events

  • 25 Oct 2005 Discontinued - Preclinical for Urinary incontinence in USA (unspecified route)
  • 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
  • 09 Nov 2000 Profile reviewed but no significant changes made
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top